NCT05189340

Brief Summary

Audiovisual teaching aids can play a significant role for the retention of new material and help overcome barriers such as the physical presence or time restrictions of an instructor. In a clinical setting, multimedia health education can offer an advantage over traditional didactic teaching by engaging patients through visual content and unlimited accessibility. A critical factor to long-term survival of solid organ transplant recipients is compliance to post-transplantation medication and follow-up patient care. Transplant pharmacists serve on multidisciplinary care teams as the medication experts that provide discharge education to recipients and caregivers often at the bedside. The adoption of digital multimedia content for patient education can increase engagement of diverse learning styles while simultaneously reducing potential time conflicts in hospital practice. This study contributes to the literature by assessing the effectiveness of discharge education video(s) on patient satisfaction and knowledge levels which are currently limited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 12, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

April 11, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 3, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2022

Completed
Last Updated

June 8, 2022

Status Verified

May 1, 2022

Enrollment Period

2 months

First QC Date

December 29, 2021

Last Update Submit

June 7, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Patient Transplant Medication and Care Knowledge

    Change in performance pre and post-education based on responses to questionnaire

    Pre- and post-education; pre-education assessment will be completed as soon as feasible after transplant (estimate 1-3 days) and consent; post-education assessment will be completed as soon as is feasible after initial education (estimate 0-2 days)

  • Patient Satisfaction with Educational Method

    Difference in satisfaction as determined by response to questionnaire post education. A single question score from 1 to 10 will be used, with 10 being highest satisfaction and 1 being the lowest level of satisfaction

    As soon as feasible post-education, in concert with post-education knowledge assessment (estimate 0-2 days)

Secondary Outcomes (1)

  • Pharmacist Time Requirement

    As soon as feasible post-education (estimate 0-2 days)

Study Arms (2)

Standard of Care

NO INTERVENTION

Patients in the Standard of Care arm will receive pharmacist discharge education via fully in-person education as is currently being done.

Intervention

EXPERIMENTAL

Patients in the Intervention arm will have access to pre-recorded educational videos covering key educational points. Patients will also have in-person interaction with pharmacists to address additional questions not covered in the videos.

Other: Educational Videos

Interventions

Series of six videos each covering a specific aspect of post-transplant care related to medication use or monitoring

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are solid organ transplant recipients at Johns Hopkins Hospital
  • Patients who are being managed by an adult solid-organ transplant surgical service
  • Patients who can speak and read the English language

You may not qualify if:

  • Patients with language access services needs will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

Study Officials

  • Ryan Whisler

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Patients in the standard of care arm will be enrolled through a specified date (currently targeting late February 2022, at which time enrolled patients will be included in the intervention group until data collection ceases in late April
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2021

First Posted

January 12, 2022

Study Start

April 11, 2022

Primary Completion

June 3, 2022

Study Completion

June 3, 2022

Last Updated

June 8, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations